Technologieangebote

Eigenverstärkte Tiefziehfolie

Die Erfindung betrifft eine tiefziehfähige Folie und ein Verfahren zur Herstellung einer tiefziehfähigen Folie.

Digitaler Multiplizierer

Die Erfindung beschreibt ein Verfahren zum Multiplizieren zweier Binärzahlen auf einem feldprogrammierbaren Logikbaustein.

Onlinebestimmung von Erntegutverlusten (Erntecheck)

Die Erfindung betrifft ein Verfahren zur Online-Erfassung von Blatt- und Stengelteilen, welche sich während der zum Trocknen von Grüngut (Heu, Silage) unverzichtbaren mechanischen Bearbeitung auf dem Feld abtrennen und so den Ertrag verringern.

Access to novel p-hydroxy styrene polymer building blocks

The technology offers a new one-pot reaction to prepare efficiently various aryl substituted p-hydroxy styrene derivatives from phenol derivatives and pyruvic acid as starting materials. The para-vinylated phenols of the enzymatic / biocatalytic reaction can be used as monomers for the production of polymers, likely novel polystyrene or polyphenol derivatives. Properties of the resulting polmyers might offer the use as flame retardant material or in electronic industry.

Phospholipids against American foulbrood and European foulbrood in honeybees

New treatment concept against two devastating honeybee larval diseases, i.e., American and European foulbrood (AFB, EFB), based on the natural compound lysophosphatidylcholine (LPC). LPC exhibits strong antibacterial activity against the causative agents of AFB and EFB and LPC supplementation to honeybee larvae was proven to reduce the outbreak of AFB significantly. The utilization of an LPC based therapy contributes to improve environmental sustainability in honeybee health and may offer new business perspectives in veterinary medicine.

Inhibitors of Adipose Triglyceride Lipase (ATGL) for the treatment of Diabetes II and tumour-induced cachexia

The University offers a new technology addressing at least the two markets of tumour-induced cachexia and diabetes type II. Cancer has become a constantly increasing problem and thus about 1 % of all people in highly developed countries are hit by cachexia, leading to approximately 9 million patients for Europe, Japan and the US. Furthermore, diabetes type II is one of the major lifestyle diseases in the modern world.

Seite
1 54 55 56 57 58 692